# A Phase I Study of AZD0424 Alone and in Combination in Advanced Solid Tumours

> **NCT01668550** · PHASE1 · TERMINATED · sponsor: **Cancer Research UK** · enrollment: 43 (actual)

## Conditions studied

- Advanced Solid Tumours

## Interventions

- **DRUG:** AZD0424

## Key facts

- **NCT ID:** NCT01668550
- **Lead sponsor:** Cancer Research UK
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-10
- **Primary completion:** 2016-05
- **Final completion:** 2016-05
- **Target enrollment:** 43 (ACTUAL)
- **Why stopped:** Single agent phase completed, insufficient supportive preclinical data to proceed with combination phase
- **Last updated:** 2018-02-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01668550

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01668550, "A Phase I Study of AZD0424 Alone and in Combination in Advanced Solid Tumours". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT01668550. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*